Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA, USA.
Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA, USA.
J Matern Fetal Neonatal Med. 2022 Dec;35(25):5346-5353. doi: 10.1080/14767058.2021.1879041. Epub 2021 Feb 1.
We aimed to decrease our surgical site infection (SSI) rate by 30% by sequential implementation of vaginal cleansing and azithromycin for women who underwent a cesarean delivery (CD) after having labored or experienced rupture of membranes.
This is a quality improvement project that assessed the stepwise implementation of two interventions within three time periods: (1) 12 months prior to implementation of either intervention; (2) 14 months of vaginal cleansing as infection prophylaxis; (3) 16 months of vaginal cleansing and azithromycin as infection prophylaxis. The primary outcome measure was the SSI as defined by the Center for Disease Control and Prevention and analyzed by control charts. The process measures were compliance rates of vaginal cleansing and azithromycin. Significance was detected by rules for determining a special cause variation. This study followed the SQUIRE 2.0 guidelines for reporting on quality improvement.
There were 1033 patients included from the three study periods. The total rate of SSI decreased from 22.8% to 15.2% after implementing vaginal cleansing. Special cause variation was detected with an 8-point shift starting 4 months after implementation of vaginal cleansing. This decrease was sustained during the following 26 months. Adding azithromycin did not significantly lower the SSI rate further. When examined separately, deep SSI ( = .009) and endometritis ( = .001) significantly decreased in the post-intervention periods. Pre-operative vaginal cleansing compliance rose to 74%, and then further increased to 85% 1 year after implementation. Azithromycin compliance rose to 75%. Total length of postpartum stay decreased over the study periods from 3.5 ± 1.4 days to 3.2 ± 0.8 days ( = .001).
In this quality improvement study, implementation of vaginal cleansing decreased the SSI rate by 33%, from 22.8% to 15.2%. The addition of azithromycin did not result in any additional change in SSI rate.
通过对经历过阴道分娩或胎膜破裂的行剖宫产术的女性进行阴道冲洗和阿奇霉素治疗,将手术部位感染(SSI)率降低 30%。
这是一项质量改进项目,在三个时期内逐步实施了两项干预措施:(1)在实施任何干预措施之前的 12 个月;(2)阴道冲洗作为感染预防措施的 14 个月;(3)阴道冲洗和阿奇霉素作为感染预防措施的 16 个月。主要结局指标为美国疾病控制与预防中心定义的 SSI,并通过控制图进行分析。过程指标为阴道冲洗和阿奇霉素的依从率。通过确定特殊原因变化的规则来检测显著性。本研究遵循 SQUIRE 2.0 报告质量改进的指南。
在三个研究期内共纳入了 1033 例患者。实施阴道冲洗后,SSI 的总发生率从 22.8%降至 15.2%。从实施阴道冲洗后 4 个月开始,特殊原因变化检测到 8 个点的转移。这种下降在接下来的 26 个月中持续存在。添加阿奇霉素并不能进一步显著降低 SSI 率。分别检查时,深部 SSI( =.009)和子宫内膜炎( =.001)在干预后期间显著降低。术前阴道冲洗的依从率从 74%上升到实施后 1 年的 85%。阿奇霉素的依从率上升到 75%。研究期间,产后住院时间从 3.5±1.4 天缩短至 3.2±0.8 天( =.001)。
在这项质量改进研究中,实施阴道冲洗将 SSI 率从 22.8%降低至 15.2%,降低了 33%。添加阿奇霉素并没有导致 SSI 率的任何进一步变化。